This document outlines information about sphenoid wing meningiomas (SWM), including:
- Background on SWM classification and locations of hyperostosis
- Causes of hyperostosis including tumor cell activity and bone stimulation
- Presentation of SWM such as headaches, visual changes, and nerve deficits
- Workup involving imaging like CT/MRI and surgical planning considerations
- Treatment including options for medical management or surgical resection via approaches like pterional or orbitozygomatic to remove tumor and resect bone
Esthesioneuroblastoma (ENB) is a rare malignant tumor that arises from the olfactory epithelium in the nasal cavity. Imaging such as CT and MRI are used to determine the extent of the tumor. Histopathological examination shows small round blue cells forming rosettes. Treatment involves surgery such as craniofacial resection along with radiation therapy. For advanced disease, chemotherapy may be given as part of multimodality treatment. With aggressive treatment, 5-year survival rates for ENB exceed 60%.
This document discusses the changing landscape of cancer of unknown primary (CUP) over four decades from 1976 to the present. It describes the evolution from recognition of favorable prognostic subsets in 1976-1986, to improved diagnostic techniques in 1986-1996, to empiric chemotherapy in 1996-2006, and currently to improved pathologic and genetic diagnostic technologies and better outcomes for many CUP patients from 2006 onward. The document provides details on histologic classification, clinicopathologic entities, diagnostic approaches including imaging, histopathology, immunohistochemistry, and molecular analysis, as well as discussion of favorable and unfavorable prognostic subsets and treatment approaches.
A 16-year-old male presented with recurrent nasal bleeding. Imaging revealed a large mass along the left nasal fossa with lobulated contours and extension into multiple compartments including the nasal cavity, sinuses, and intracranial space. The mass showed intermediate signal intensity on T2-weighted imaging with a macrocyst along the periphery of the intracranial component. These features are characteristic of an olfactory neuroblastoma, also known as esthesioneuroblastoma, which arises from the olfactory epithelium and commonly involves multiple nasal compartments with cyst formation along the intracranial periphery.
Pineal gland is essentially an extra axial midline structure lying at the roof of dienchephalon rostral to the quadrigeminal cistern surrounded by important neurovascular structure, occurring in the geometric center of brain with same depth of trajectory had made the surgery in this region a formidable challenge to neurosurgeons, however radical resection must be the goal in selected pathologies, if not pure germ cell tumor.
WHO BRAIN TUMOR CLASSIFICATION 5th EDITIONKanhu Charan
The document summarizes some of the key changes in the 2021 5th edition of the WHO brain tumor classification compared to previous editions. Some notable changes include recognizing the distinction between adult and pediatric diffuse gliomas, adding 22 new tumor types, revising the terminology for 13 tumor types, introducing essential and desirable diagnostic criteria, and classifying tumors based on a combination of histopathological and molecular features. Sellar tumors, meningiomas, and ependymomas were also revised in the new classification system.
Mr. Sunil, a 72-year-old male, presented with a 3-month history of a left neck swelling. Further examinations revealed metastatic squamous cell carcinoma in the left neck lymph nodes. He was diagnosed with carcinoma of unknown primary (CUP) and underwent radical neck dissection, followed by chemotherapy and radiotherapy. CUP describes metastatic cancers where the primary site cannot be identified despite various examinations and evaluations. Treatment options for CUP include surgery, radiation therapy, chemotherapy, or concurrent chemoradiation depending on the lymph node involvement and other factors. Prognosis depends on the stage and presence of extracapsular extension, with 5-year survival rates ranging from 30% for upper cervical nodes to 5%
The document discusses posterior fossa tumors. It begins by outlining the anatomy of the posterior fossa and then provides background information on posterior fossa tumors. It states that 60-70% of pediatric brain tumors and 15-20% of adult brain tumors originate in the posterior fossa. The document then covers various tumor types found in the posterior fossa, including hemangioblastoma, brain metastases, and medulloblastoma. It provides details on the clinical presentation, imaging, pathology, treatment and prognosis for each of these tumor types.
This document outlines information about sphenoid wing meningiomas (SWM), including:
- Background on SWM classification and locations of hyperostosis
- Causes of hyperostosis including tumor cell activity and bone stimulation
- Presentation of SWM such as headaches, visual changes, and nerve deficits
- Workup involving imaging like CT/MRI and surgical planning considerations
- Treatment including options for medical management or surgical resection via approaches like pterional or orbitozygomatic to remove tumor and resect bone
Esthesioneuroblastoma (ENB) is a rare malignant tumor that arises from the olfactory epithelium in the nasal cavity. Imaging such as CT and MRI are used to determine the extent of the tumor. Histopathological examination shows small round blue cells forming rosettes. Treatment involves surgery such as craniofacial resection along with radiation therapy. For advanced disease, chemotherapy may be given as part of multimodality treatment. With aggressive treatment, 5-year survival rates for ENB exceed 60%.
This document discusses the changing landscape of cancer of unknown primary (CUP) over four decades from 1976 to the present. It describes the evolution from recognition of favorable prognostic subsets in 1976-1986, to improved diagnostic techniques in 1986-1996, to empiric chemotherapy in 1996-2006, and currently to improved pathologic and genetic diagnostic technologies and better outcomes for many CUP patients from 2006 onward. The document provides details on histologic classification, clinicopathologic entities, diagnostic approaches including imaging, histopathology, immunohistochemistry, and molecular analysis, as well as discussion of favorable and unfavorable prognostic subsets and treatment approaches.
A 16-year-old male presented with recurrent nasal bleeding. Imaging revealed a large mass along the left nasal fossa with lobulated contours and extension into multiple compartments including the nasal cavity, sinuses, and intracranial space. The mass showed intermediate signal intensity on T2-weighted imaging with a macrocyst along the periphery of the intracranial component. These features are characteristic of an olfactory neuroblastoma, also known as esthesioneuroblastoma, which arises from the olfactory epithelium and commonly involves multiple nasal compartments with cyst formation along the intracranial periphery.
Pineal gland is essentially an extra axial midline structure lying at the roof of dienchephalon rostral to the quadrigeminal cistern surrounded by important neurovascular structure, occurring in the geometric center of brain with same depth of trajectory had made the surgery in this region a formidable challenge to neurosurgeons, however radical resection must be the goal in selected pathologies, if not pure germ cell tumor.
WHO BRAIN TUMOR CLASSIFICATION 5th EDITIONKanhu Charan
The document summarizes some of the key changes in the 2021 5th edition of the WHO brain tumor classification compared to previous editions. Some notable changes include recognizing the distinction between adult and pediatric diffuse gliomas, adding 22 new tumor types, revising the terminology for 13 tumor types, introducing essential and desirable diagnostic criteria, and classifying tumors based on a combination of histopathological and molecular features. Sellar tumors, meningiomas, and ependymomas were also revised in the new classification system.
Mr. Sunil, a 72-year-old male, presented with a 3-month history of a left neck swelling. Further examinations revealed metastatic squamous cell carcinoma in the left neck lymph nodes. He was diagnosed with carcinoma of unknown primary (CUP) and underwent radical neck dissection, followed by chemotherapy and radiotherapy. CUP describes metastatic cancers where the primary site cannot be identified despite various examinations and evaluations. Treatment options for CUP include surgery, radiation therapy, chemotherapy, or concurrent chemoradiation depending on the lymph node involvement and other factors. Prognosis depends on the stage and presence of extracapsular extension, with 5-year survival rates ranging from 30% for upper cervical nodes to 5%
The document discusses posterior fossa tumors. It begins by outlining the anatomy of the posterior fossa and then provides background information on posterior fossa tumors. It states that 60-70% of pediatric brain tumors and 15-20% of adult brain tumors originate in the posterior fossa. The document then covers various tumor types found in the posterior fossa, including hemangioblastoma, brain metastases, and medulloblastoma. It provides details on the clinical presentation, imaging, pathology, treatment and prognosis for each of these tumor types.
Presentation1.pptx sellar and para sellar massesAbdellah Nazeer
The document provides information on imaging techniques and differential diagnosis for sellar and parasellar masses. CT and MRI techniques are described for imaging the sella turcica region with details on slice thickness, field of view, and contrast usage. An anatomic approach is outlined to analyze sellar masses which involves identifying the pituitary gland, lesion location and characteristics, and establishing a differential diagnosis. Common pathologies that can occur in the sella and surrounding structures are then described individually, including the pituitary gland, stalk, optic chiasm, hypothalamus, carotid artery, cavernous sinus, and meninges. Imaging examples of lesions such as pituitary adenomas, craniopharyngiomas, and meningi
This document discusses various tumors and lesions that can occur in the posterior fossa region of the brain. It provides CT and MRI images and descriptions of common tumors in this area, including medulloblastoma, ependymoma, choroid plexus papilloma, brain stem gliomas, gangliogliomas, pilocytic astrocytomas, hemangioblastomas, and metastases from other cancers. The document is intended as an imaging guide for physicians to identify and diagnose different infra-tentorial lesions and tumors based on scan findings.
This document presents a history and physical examination (H&P) for a 47-year-old female patient referred for evaluation of a right neck mass. The mass had been present for 9 years and was recently growing steadily. Imaging revealed large enhancing bilateral carotid body tumors. Carotid body tumors are rare neuroendocrine tumors that typically arise from paraganglia near the carotid bifurcation. The patient underwent preoperative embolization followed by surgical resection of the right tumor via a transparotid approach, which resulted in temporary right vocal cord paralysis requiring a feeding tube.
Craniopharyngioma is thought to arise from ectodermally derived epithelial remnants of rathke’s pouch and there craniopharyngeal duct.
Neoplastic transformation of cells derived from tooth primordia give rise to adamantinomatous craniopharnygioma, whereas
such transformation in cells derived from buccal mucosa primodia give rise to papillary type
Meningioma is a type of tumor that arises from the meninges, the protective layers surrounding the brain and spinal cord. It is the most common primary brain tumor, accounting for about 20% of all primary central nervous system tumors. Meningiomas most often occur in adults and are more common in women. While the majority of meningiomas are benign, radiation exposure, genetic conditions, and hormone therapy can increase the risk of a malignant type. Imaging plays an important role in the diagnosis and treatment planning of meningiomas.
Carcinoma nasopharynx anatomy to managementDrAyush Garg
The document provides an overview of carcinoma of the nasopharynx, including its:
1) Anatomy, blood and lymphatic supply, patterns of spread, and related spaces like the fossa of Rosenmuller and parapharyngeal space.
2) Clinical presentation, diagnostic evaluation including endoscopy, biopsy, imaging modalities like MRI and CT, serum markers, and staging systems.
3) Etiology involving genetic, environmental, and viral factors. Epstein-Barr virus is implicated in over 90% of undifferentiated carcinoma of the nasopharynx.
Dr. Kiran Kumar discusses the management of pituitary tumors. Pituitary tumors are most commonly found in adults aged 30-60 years and can cause hormonal issues or mass effect symptoms. Diagnostic evaluation involves blood tests, MRI imaging, and visual field testing. Treatment options include observation for small asymptomatic tumors, medication to control hormone levels, surgery to remove the tumor, and radiation therapy as an adjuvant treatment or for inoperable tumors. The goals of treatment are to remove the tumor, control hypersecretion, and preserve pituitary function without injury to surrounding structures.
The document provides an overview of common lesions found in the cerebellopontine angle (CPA) region, including their anatomy, clinical features, radiology, and differential diagnosis. It discusses several pathologies that can occur in the CPA such as acoustic neuromas/vestibular schwannomas, meningiomas, epidermoids, arachnoid cysts, and trigeminal neuromas. For each condition, it outlines key diagnostic elements on imaging studies like CT and MRI scans that can help differentiate between possible lesions.
This document discusses craniopharyngioma, a rare brain tumor that arises near the pituitary gland. It has a bimodal age distribution in children and adolescents. Surgical removal is the primary treatment but can be challenging due to the tumor's location near vital structures. The goals of surgery are complete removal while preserving neurological function. Radiation and chemotherapy may also be used for residual or recurrent tumors. Ongoing monitoring is important due to the risk of the tumor returning after initial treatment.
This document discusses central nervous system (CNS) tumors. It begins by dividing CNS tumors into primary tumors, which originate in the brain, and secondary tumors, which have metastasized from other parts of the body. It then covers various types and grading systems of CNS tumors, including gliomas, the most common primary malignant brain tumors. Specific low-grade gliomas such as astrocytomas, oligodendrogliomas, and oligoastrocytomas are discussed in detail. Treatment options mentioned include observation, supportive care, surgery such as biopsy or resection, and chemotherapy or radiation.
Carcinoma of the maxillary sinus is rare, constituting 3-5% of head and neck cancers. The maxillary sinus is the most common site. Anatomy of the maxilla includes processes, surfaces, and articulations with other bones. Maxillary sinus boundaries include the roof, medial wall, floor, and buttresses. Ohngren's line divides lesions into suprastructure and infrastructure types. Spread can occur via routes like the pterygomaxillary space. Risk factors include wood dust and HPV. Pathology is usually squamous cell carcinoma. Symptoms include oral, nasal, auditory, and facial issues. Diagnosis involves imaging like CT and MRI. Management involves surgery with or without radiation depending on
This document discusses oropharyngeal cancers. It begins with the anatomy of the oropharynx and its boundaries. It then discusses the epidemiology, risk factors, clinical features, staging, workup, and management of oropharyngeal cancers. Early stage cancers are often treated with either radiotherapy or surgery alone, while locoregionally advanced cancers may be treated with surgery followed by radiation and chemotherapy or with primary chemoradiation. HPV-associated oropharyngeal cancers often have a better prognosis than HPV-negative cancers.
This document discusses cancer of the nasopharynx (NPC). Some key points:
- NPC is uncommon globally but more common in certain regions like Southern China.
- Risk factors include EBV infection, consumption of salted fish.
- Staging involves MRI and biopsy. Treatment depends on stage but often involves chemotherapy and radiation therapy.
- Advanced stages may receive neoadjuvant chemo followed by concurrent chemo-radiation. IMRT has improved treatment.
- Sequelae can include cranial neuropathy, xerostomia, endocrine issues. Lifelong follow up is needed due to risk of recurrence or second cancers. Outcomes have improved but salvage options after relapse present challenges
Carcinoma nasopharynx anatomy to managementDrAyush Garg
The document provides information on carcinoma of the nasopharynx, including its anatomy, epidemiology, etiology, clinical features, patterns of spread, diagnostic evaluation, and metastatic workup. The key points are:
1) Nasopharyngeal carcinoma is most common in Southern Chinese populations and has a bimodal age distribution. Viral, genetic, and environmental factors like Epstein-Barr virus and salted fish contribute to its etiology.
2) The tumor can spread superiorly into the skull base, anteriorly into the nasal cavity/sinuses, and posteriorly into neck muscles and brain. Distant metastases most often involve bones and lungs.
3) Diagnostic evaluation includes endoscopic
This document discusses tumors of the hypopharynx, including both benign and malignant tumors. It notes that malignant tumors are more common, especially squamous cell carcinomas. The three main subsites that can be affected are the pyriform sinus (60% of cases), postcricoid region (30% of cases), and posterior pharyngeal wall (10% of cases). For each subsite, it describes characteristics like prevalence, spread patterns, clinical features, diagnosis, and treatment options.
The document discusses the anatomy, histology, epidemiology, clinical features, diagnosis, staging, and treatment of nasopharyngeal carcinoma (NPC). Key points include:
- NPC originates from the epithelial lining of the nasopharynx.
- It has a strong association with Epstein-Barr virus.
- Risk factors include genetic predisposition and environmental exposures like salted fish consumption.
- Common symptoms are cervical lymphadenopathy, epistaxis, ear symptoms, and neurological deficits.
- Diagnosis involves biopsy and serological testing for EBV markers.
- Staging systems consider tumor size, node involvement, and serological factors.
- Primary treatment is radiotherapy,
This document provides an overview of the anatomy of the temporal bone as visualized on HRCT scans. It describes the 3 main planes of scanning and their utility. It then details the individual bones that make up the temporal bone and the external, middle, and inner ear structures. Numerous axial, coronal, and sagittal HRCT images are presented to illustrate key anatomic landmarks and relationships. Structures like the ossicles, facial nerve canal, internal auditory canal, labyrinthine and cochlear anatomy are specifically called out.
Soft tissue sarcomas account for less than 1% of malignant tumors but around 40% of patients die from the disease. While most soft tissue sarcomas have no clear cause, some risk factors include genetic predispositions, prior radiation therapy, and chemical exposure. A recent study found that over 50% of soft tissue sarcoma patients have a germline genetic variant contributing to tumor development. Diagnosis involves biopsy or imaging like CT or MRI. Treatment depends on location and grade, with surgery to remove the tumor with margins. High-risk cases may also receive radiation therapy or chemotherapy.
Low grade gliomas are slow-growing brain tumors that are divided into grades I and II. Grade I tumors have low proliferation and discrete imaging features, while grade II tumors often present with seizures and have nuclear atypia and infiltration on imaging. Molecular markers like IDH1 mutations, 1p19q co-deletions, and MGMT methylation correlate with improved survival. Initial management involves seizure control and surgery if symptomatic, followed by radiotherapy and chemotherapy depending on factors like age, symptoms, and molecular characteristics. Long-term follow up is needed due to the risk of progression to higher grade glioma over time.
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
Dr. Ebony Hoskins, gynecologic oncologist at MedStar Washington Hospital Center, provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Hoskins breaks down the research presented at the conference, discusses new developments, and addresses the most pressing questions.
Presentation1.pptx sellar and para sellar massesAbdellah Nazeer
The document provides information on imaging techniques and differential diagnosis for sellar and parasellar masses. CT and MRI techniques are described for imaging the sella turcica region with details on slice thickness, field of view, and contrast usage. An anatomic approach is outlined to analyze sellar masses which involves identifying the pituitary gland, lesion location and characteristics, and establishing a differential diagnosis. Common pathologies that can occur in the sella and surrounding structures are then described individually, including the pituitary gland, stalk, optic chiasm, hypothalamus, carotid artery, cavernous sinus, and meninges. Imaging examples of lesions such as pituitary adenomas, craniopharyngiomas, and meningi
This document discusses various tumors and lesions that can occur in the posterior fossa region of the brain. It provides CT and MRI images and descriptions of common tumors in this area, including medulloblastoma, ependymoma, choroid plexus papilloma, brain stem gliomas, gangliogliomas, pilocytic astrocytomas, hemangioblastomas, and metastases from other cancers. The document is intended as an imaging guide for physicians to identify and diagnose different infra-tentorial lesions and tumors based on scan findings.
This document presents a history and physical examination (H&P) for a 47-year-old female patient referred for evaluation of a right neck mass. The mass had been present for 9 years and was recently growing steadily. Imaging revealed large enhancing bilateral carotid body tumors. Carotid body tumors are rare neuroendocrine tumors that typically arise from paraganglia near the carotid bifurcation. The patient underwent preoperative embolization followed by surgical resection of the right tumor via a transparotid approach, which resulted in temporary right vocal cord paralysis requiring a feeding tube.
Craniopharyngioma is thought to arise from ectodermally derived epithelial remnants of rathke’s pouch and there craniopharyngeal duct.
Neoplastic transformation of cells derived from tooth primordia give rise to adamantinomatous craniopharnygioma, whereas
such transformation in cells derived from buccal mucosa primodia give rise to papillary type
Meningioma is a type of tumor that arises from the meninges, the protective layers surrounding the brain and spinal cord. It is the most common primary brain tumor, accounting for about 20% of all primary central nervous system tumors. Meningiomas most often occur in adults and are more common in women. While the majority of meningiomas are benign, radiation exposure, genetic conditions, and hormone therapy can increase the risk of a malignant type. Imaging plays an important role in the diagnosis and treatment planning of meningiomas.
Carcinoma nasopharynx anatomy to managementDrAyush Garg
The document provides an overview of carcinoma of the nasopharynx, including its:
1) Anatomy, blood and lymphatic supply, patterns of spread, and related spaces like the fossa of Rosenmuller and parapharyngeal space.
2) Clinical presentation, diagnostic evaluation including endoscopy, biopsy, imaging modalities like MRI and CT, serum markers, and staging systems.
3) Etiology involving genetic, environmental, and viral factors. Epstein-Barr virus is implicated in over 90% of undifferentiated carcinoma of the nasopharynx.
Dr. Kiran Kumar discusses the management of pituitary tumors. Pituitary tumors are most commonly found in adults aged 30-60 years and can cause hormonal issues or mass effect symptoms. Diagnostic evaluation involves blood tests, MRI imaging, and visual field testing. Treatment options include observation for small asymptomatic tumors, medication to control hormone levels, surgery to remove the tumor, and radiation therapy as an adjuvant treatment or for inoperable tumors. The goals of treatment are to remove the tumor, control hypersecretion, and preserve pituitary function without injury to surrounding structures.
The document provides an overview of common lesions found in the cerebellopontine angle (CPA) region, including their anatomy, clinical features, radiology, and differential diagnosis. It discusses several pathologies that can occur in the CPA such as acoustic neuromas/vestibular schwannomas, meningiomas, epidermoids, arachnoid cysts, and trigeminal neuromas. For each condition, it outlines key diagnostic elements on imaging studies like CT and MRI scans that can help differentiate between possible lesions.
This document discusses craniopharyngioma, a rare brain tumor that arises near the pituitary gland. It has a bimodal age distribution in children and adolescents. Surgical removal is the primary treatment but can be challenging due to the tumor's location near vital structures. The goals of surgery are complete removal while preserving neurological function. Radiation and chemotherapy may also be used for residual or recurrent tumors. Ongoing monitoring is important due to the risk of the tumor returning after initial treatment.
This document discusses central nervous system (CNS) tumors. It begins by dividing CNS tumors into primary tumors, which originate in the brain, and secondary tumors, which have metastasized from other parts of the body. It then covers various types and grading systems of CNS tumors, including gliomas, the most common primary malignant brain tumors. Specific low-grade gliomas such as astrocytomas, oligodendrogliomas, and oligoastrocytomas are discussed in detail. Treatment options mentioned include observation, supportive care, surgery such as biopsy or resection, and chemotherapy or radiation.
Carcinoma of the maxillary sinus is rare, constituting 3-5% of head and neck cancers. The maxillary sinus is the most common site. Anatomy of the maxilla includes processes, surfaces, and articulations with other bones. Maxillary sinus boundaries include the roof, medial wall, floor, and buttresses. Ohngren's line divides lesions into suprastructure and infrastructure types. Spread can occur via routes like the pterygomaxillary space. Risk factors include wood dust and HPV. Pathology is usually squamous cell carcinoma. Symptoms include oral, nasal, auditory, and facial issues. Diagnosis involves imaging like CT and MRI. Management involves surgery with or without radiation depending on
This document discusses oropharyngeal cancers. It begins with the anatomy of the oropharynx and its boundaries. It then discusses the epidemiology, risk factors, clinical features, staging, workup, and management of oropharyngeal cancers. Early stage cancers are often treated with either radiotherapy or surgery alone, while locoregionally advanced cancers may be treated with surgery followed by radiation and chemotherapy or with primary chemoradiation. HPV-associated oropharyngeal cancers often have a better prognosis than HPV-negative cancers.
This document discusses cancer of the nasopharynx (NPC). Some key points:
- NPC is uncommon globally but more common in certain regions like Southern China.
- Risk factors include EBV infection, consumption of salted fish.
- Staging involves MRI and biopsy. Treatment depends on stage but often involves chemotherapy and radiation therapy.
- Advanced stages may receive neoadjuvant chemo followed by concurrent chemo-radiation. IMRT has improved treatment.
- Sequelae can include cranial neuropathy, xerostomia, endocrine issues. Lifelong follow up is needed due to risk of recurrence or second cancers. Outcomes have improved but salvage options after relapse present challenges
Carcinoma nasopharynx anatomy to managementDrAyush Garg
The document provides information on carcinoma of the nasopharynx, including its anatomy, epidemiology, etiology, clinical features, patterns of spread, diagnostic evaluation, and metastatic workup. The key points are:
1) Nasopharyngeal carcinoma is most common in Southern Chinese populations and has a bimodal age distribution. Viral, genetic, and environmental factors like Epstein-Barr virus and salted fish contribute to its etiology.
2) The tumor can spread superiorly into the skull base, anteriorly into the nasal cavity/sinuses, and posteriorly into neck muscles and brain. Distant metastases most often involve bones and lungs.
3) Diagnostic evaluation includes endoscopic
This document discusses tumors of the hypopharynx, including both benign and malignant tumors. It notes that malignant tumors are more common, especially squamous cell carcinomas. The three main subsites that can be affected are the pyriform sinus (60% of cases), postcricoid region (30% of cases), and posterior pharyngeal wall (10% of cases). For each subsite, it describes characteristics like prevalence, spread patterns, clinical features, diagnosis, and treatment options.
The document discusses the anatomy, histology, epidemiology, clinical features, diagnosis, staging, and treatment of nasopharyngeal carcinoma (NPC). Key points include:
- NPC originates from the epithelial lining of the nasopharynx.
- It has a strong association with Epstein-Barr virus.
- Risk factors include genetic predisposition and environmental exposures like salted fish consumption.
- Common symptoms are cervical lymphadenopathy, epistaxis, ear symptoms, and neurological deficits.
- Diagnosis involves biopsy and serological testing for EBV markers.
- Staging systems consider tumor size, node involvement, and serological factors.
- Primary treatment is radiotherapy,
This document provides an overview of the anatomy of the temporal bone as visualized on HRCT scans. It describes the 3 main planes of scanning and their utility. It then details the individual bones that make up the temporal bone and the external, middle, and inner ear structures. Numerous axial, coronal, and sagittal HRCT images are presented to illustrate key anatomic landmarks and relationships. Structures like the ossicles, facial nerve canal, internal auditory canal, labyrinthine and cochlear anatomy are specifically called out.
Soft tissue sarcomas account for less than 1% of malignant tumors but around 40% of patients die from the disease. While most soft tissue sarcomas have no clear cause, some risk factors include genetic predispositions, prior radiation therapy, and chemical exposure. A recent study found that over 50% of soft tissue sarcoma patients have a germline genetic variant contributing to tumor development. Diagnosis involves biopsy or imaging like CT or MRI. Treatment depends on location and grade, with surgery to remove the tumor with margins. High-risk cases may also receive radiation therapy or chemotherapy.
Low grade gliomas are slow-growing brain tumors that are divided into grades I and II. Grade I tumors have low proliferation and discrete imaging features, while grade II tumors often present with seizures and have nuclear atypia and infiltration on imaging. Molecular markers like IDH1 mutations, 1p19q co-deletions, and MGMT methylation correlate with improved survival. Initial management involves seizure control and surgery if symptomatic, followed by radiotherapy and chemotherapy depending on factors like age, symptoms, and molecular characteristics. Long-term follow up is needed due to the risk of progression to higher grade glioma over time.
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
Dr. Ebony Hoskins, gynecologic oncologist at MedStar Washington Hospital Center, provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Hoskins breaks down the research presented at the conference, discusses new developments, and addresses the most pressing questions.
This document summarizes key information about ovarian cancer, including epidemiology, risk factors, screening, staging, treatment with surgery and chemotherapy. It notes that ovarian cancer incidence is stable worldwide, with most women diagnosed at advanced stage. Screening with CA125 and ultrasound has not proven mortality benefit. Surgical staging and optimal debulking improves outcomes, while platinum-based chemotherapy is standard first-line treatment and improves survival. Ongoing research focuses on maintenance therapies and intraperitoneal chemotherapy administration.
This document summarizes key information about ovarian cancer, including epidemiology, risk factors, screening, staging, treatment with surgery and chemotherapy. It notes that ovarian cancer incidence is stable worldwide, with most women diagnosed at advanced stage. Screening with CA125 and ultrasound has not proven mortality benefit. Surgical staging and optimal debulking improves outcomes, while platinum-based chemotherapy is standard first-line treatment and improves survival. Ongoing research evaluates incorporating targeted therapies and intraperitoneal chemotherapy administration.
Hypofractionated radiotherapy regimens are being re-explored for their potential logistical benefits compared to conventionally fractionated radiotherapy. Several studies have evaluated hypofractionation for prostate cancer, finding comparable rates of tumor control and acceptable toxicity profiles. The CHHiP trial directly compared 57Gy in 19 fractions to 74Gy in 37 fractions for prostate cancer, finding no significant differences in patient-reported bowel symptoms up to 2 years post-treatment.
1) The PORTEC-1 and PORTEC-2 trials compared pelvic radiotherapy to no additional treatment or vaginal brachytherapy for patients with endometrial carcinoma. PORTEC-1 found pelvic radiotherapy reduced vaginal recurrence while PORTEC-2 found vaginal brachytherapy achieved excellent vaginal control with fewer side effects compared to pelvic radiotherapy.
2) The PORTEC-3 trial randomized 686 patients with high risk endometrial cancer to chemoradiotherapy or radiotherapy alone. It found chemoradiotherapy improved failure-free survival compared to radiotherapy alone, especially for stage III patients, but with increased toxicity.
3)
Hypofractionated radiotherapy regimens provide comparable tumour control to conventional fractionation for several cancer types based on multiple studies. For prostate cancer, studies found hypofractionated regimens of 57Gy in 19 fractions and 60Gy in 20 fractions resulted in similar biochemical control and toxicity outcomes as 74Gy in 37 fractions at median follow ups of 5 years. However, a larger study found 64.6Gy in 19 fractions significantly increased grade 3 gastrointestinal toxicity compared to 78Gy in 39 fractions for intermediate-high risk prostate cancer. Estimated alpha/beta ratios from studies on breast and other cancers support hypofractionation for tissues with low alpha/beta ratios.
This document summarizes key information about ovarian cancer, including:
- It is the fourth leading cause of cancer death in women in developed countries.
- Most women are diagnosed at an advanced stage when symptoms appear.
- Surgery is the initial treatment to obtain a diagnosis, perform staging, and attempt to debulk the tumor.
- Platinum-based chemotherapy with carboplatin and paclitaxel is the standard first-line treatment, though some studies show improved outcomes with dose-dense regimens.
Colorectal cancer - adjuvant Rx - Nicola Tannerwelshbarbers
This document discusses treatment principles for colorectal cancer including histological staging, chemotherapy, surgery, and trials. It covers adjuvant therapies for colon and rectal cancers including chemotherapy with or without radiotherapy. It also discusses neoadjuvant treatments and timelines for administering adjuvant therapies. Key points covered include Dukes staging, 5-year survival rates by stage, aims of adjuvant therapy, and common surgeries for colon and rectal cancers.
Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)Joseph A. Di Como MD
This document discusses soft tissue sarcomas (STS), a rare type of cancer that arises in connective tissues like muscles or fat. It notes that STS account for about 1% of adult cancers in the US, with most occurring in extremities or trunk. Risk factors include radiation exposure, certain chemicals, and genetic conditions. STS are classified and graded based on cell type and differentiation. Treatment typically involves surgical resection with clear margins, sometimes combined with radiation or chemotherapy depending on stage, grade, and location. Prognosis depends on stage and grade, with 5-year survival rates ranging from 54-65% after complete resection of primary retroperitoneal sarcomas.
This document discusses chemotherapy for gliomas. It begins by covering early trials of carmustine for glioblastoma in the 1960s. It then summarizes the landmark 2005 Stupp trial which showed improved survival with temozolomide combined with radiation therapy for newly diagnosed glioblastoma. The document also discusses trials of bevacizumab and other targeted therapies as well as immunotherapy approaches. It reviews treatment options for recurrent glioblastoma and anaplastic glioma. Finally, it briefly discusses chemotherapy approaches and trials for low-grade gliomas in both adults and children.
Ovarian cancer is the fourth leading cause of cancer death in women. Most women are diagnosed at an advanced stage due to non-specific symptoms. While screening may detect some early stage cancers, no screening strategy has proven to reduce mortality. Standard treatment is surgical staging and debulking followed by chemotherapy with carboplatin and paclitaxel, though some studies suggest dose-dense or alternative schedules may improve outcomes.
Management of locally advanced ovarian, fallopian tube, and peritoneal tumors requires a comprehensive and multidisciplinary approach. Locally advanced tumors are those that have spread beyond the ovaries or fallopian tubes and may involve nearby structures, such as the peritoneum or adjacent organs. Here's a brief overview of the management strategies:
Surgery:
Debulking Surgery: The primary treatment for locally advanced tumors involves cytoreductive or debulking surgery. This aims to remove as much of the tumor as possible. Surgeons may perform a total hysterectomy, bilateral salpingo-oophorectomy, and removal of involved peritoneal tissues.
Lymphadenectomy: Lymph node dissection is often done to assess the extent of the disease spread and to remove involved lymph nodes.
Chemotherapy:
Neoadjuvant Chemotherapy: In some cases, chemotherapy may be administered before surgery to shrink the tumor, making surgery more effective.
Adjuvant Chemotherapy: Following surgery, chemotherapy is typically recommended to target any remaining cancer cells. Platinum-based chemotherapy regimens are commonly used.
Targeted Therapies:
PARP Inhibitors: Poly (ADP-ribose) polymerase inhibitors, such as olaparib and niraparib, have shown efficacy in treating ovarian and related cancers with specific genetic mutations, like BRCA mutations.
Immunotherapy:
Checkpoints Inhibitors: Immune checkpoint inhibitors, like pembrolizumab and nivolumab, may be considered in cases with specific molecular profiles.
Radiation Therapy:
External Beam Radiation: In some situations, radiation therapy may be used to target specific areas affected by the tumor.
Clinical Trials:
Participation in clinical trials may be an option for patients with locally advanced disease, offering access to innovative treatments and therapies.
Follow-up Care:
Regular monitoring and follow-up care are crucial to assess treatment effectiveness and detect any signs of recurrence.
Palliative Care:
Palliative care should be integrated into the management plan to address symptom control, improve quality of life, and provide support for both the patient and their family.
A personalized treatment plan should be developed based on the specific characteristics of the tumor, the patient's overall health, and individual factors. Regular communication among a multidisciplinary team, including surgeons, medical oncologists, radiation oncologists, and other specialists, is essential for optimizing the management of locally advanced ovarian, fallopian tube, and peritoneal tumors.
This document provides information on ovarian cancer including:
1. Epidemiology statistics such as incidence rates, median age of diagnosis, and high rates of late stage diagnosis.
2. Details on cancer staging and 5-year survival rates which vary significantly based on stage.
3. Risk factors such as age, family history, and genetic mutations.
4. Guidelines that do not recommend screening for the general population due to low detection rates of early-stage cancer and potential for harm.
5. Surgical staging and debulking is the initial management approach along with chemotherapy, typically carboplatin and paclitaxel, though some studies explored improved schedules.
This document provides an overview of the management of gliomas. It discusses the general management and specific management of low grade and high grade gliomas.
For low grade gliomas, the main treatment options are observation, surgery, radiation, and chemotherapy. Surgery aims for maximal safe resection followed by radiation therapy. Chemotherapy with PCV may provide a survival benefit for high risk patients based on one trial, but requires further study.
For high grade gliomas, prognostic factors like age, performance status, extent of resection, and molecular markers are discussed. Treatment involves maximal safe surgery followed by concurrent chemoradiation and adjuvant chemotherapy with temozolomide, which has become the standard of care based on clinical trials
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with rapid growth and early metastasis. SCLC is usually responsive to initial chemotherapy but often relapses within two years. The standard first-line treatment is platinum-based chemotherapy such as etoposide plus cisplatin or carboplatin. Adding thoracic radiotherapy to chemotherapy improves survival for limited-stage disease. Many clinical trials have evaluated additional agents or alternative regimens but no significant improvements in outcomes have been achieved compared to standard etoposide plus platinum chemotherapy.
This document summarizes advances in the treatment of T cell lymphomas. It discusses that T cell lymphomas are a heterogeneous group that require different treatment strategies. Autologous stem cell transplantation improves outcomes for patients who achieve complete remission. Allogeneic stem cell transplantation may provide long-term remissions for nodal T cell lymphomas but has higher non-relapse mortality. Novel agents like romidepsin and bendamustine show promising response rates in relapsed/refractory disease. Overall, stem cell transplantation improves survival when given in the frontline or chemotherapy-sensitive setting, but optimal primary chemotherapy regimens need further refinement to get more patients to transplant.
The document discusses various types of primary and metastatic brain tumors. It provides statistics on the annual incidence of different brain tumors in the US. It then describes several specific tumor types in more detail, including meningiomas, vestibular schwannomas, craniopharyngiomas, gliomas such as glioblastoma, and brain metastases. For each tumor type, it discusses epidemiology, presentation, imaging, histopathology, treatment including surgery and radiotherapy techniques and dose/fractionation schedules.
A 71-year-old female presented with abdominal pain and weight loss. Imaging showed a mass in the pancreatic body involving nearby vessels. This represents locally advanced, unresectable pancreatic cancer. Treatment options include chemotherapy, radiation therapy, or chemoradiation to help control symptoms and prolong survival, though the prognosis remains poor. Surgery may be considered if the tumor significantly shrinks with neoadjuvant therapy.
Omission of RT in elderly breast cancer patientsBharti Devnani
This journal club presentation summarized the PRIME II randomized controlled trial which evaluated the efficacy of postoperative whole-breast radiotherapy for women aged 65 years or older with early-stage, hormone receptor-positive breast cancer treated with breast-conserving surgery and adjuvant endocrine therapy. The results showed that radiotherapy achieved a significant but relatively small reduction in local breast recurrence at 5 years compared to no radiotherapy. However, the 5-year rate of recurrence was low enough that omission of radiotherapy could be considered for select low-risk patients based on tumor characteristics and patient preferences. Treatment decisions require individualization based on prognostic factors and risk-benefit assessment.
Anterior-o-lateral approach to thoraco lumbar regionZeeshan Nasir
1) The anterior-lateral approach to the thoracolumbar region provides wide exposure of the vertebral column and is used for pathologies like trauma, degenerative disc disease, tumors, infections, and deformities.
2) The surgical technique involves making an incision along the superior margin of the 10th or 12th rib and dissecting the rib from its muscle attachments to access the pleural cavity or retroperitoneal space.
3) During the procedure, segmental vessels are cauterized and the artery of Adamkiewicz is identified to avoid paraplegia if injured. Injury to the cisterna chyli can also lead to lymphocele or chyl
This document provides information about anterior cervical corpectomy procedures. It describes the indications for corpectomies as involving vertebral body tumors, fractures, or infections compressing neural elements. It outlines the patient positioning and surgical steps, including incision, exposure of vertebrae, removal of disk material above and below the corpectomy level, thinning the vertebral body with a burr, grafting the defect, and potential plating. Complications are listed as wound issues, dysphagia, nerve or spinal cord injuries, bleeding, or graft failures. Post-op care involves immobilization and physiotherapy with high fusion and symptom improvement rates.
This document discusses the surgical treatment of Chiari I decompression. It outlines the indications for surgery as symptoms of pain, limb weakness, and balance issues or signs like hyperactive reflexes. It describes the surgical positioning and options for dural flaps or scoring. Post-operative complications may include CSF leak, pseudomeningocele, cerebellar ptosis, or injury to blood vessels. Most patients experience pain relief after surgery, while weakness is less responsive. The best management of a post-operative pseudomeningocele is oversewing the site with a lumbar drain and head elevation.
This document discusses surgical options for treating spasticity. It begins by defining spasticity and describing its two components: dynamic and fixed stiffness. Surgical options discussed include selective peripheral neurotomies, intrathecal baclofen, and botulinum toxin injections. Specific neurotomies of the obturator, hamstring, tibial, femoral, and median nerves are covered. Dorsal rhizotomies and DREZotomy procedures performed at the spinal cord are also summarized. Post-operative complications like sensory disturbance and recurrence of spasticity are mentioned. The goal of spasticity surgery is to reduce excessive muscle tone and tension to improve function and prevent deformities.
1. Low grade gliomas are relatively slow growing brain tumors that typically occur in younger people and have better survival rates than high grade gliomas.
2. Treatment options for low grade gliomas include observation, biopsy, surgical resection, radiotherapy, chemotherapy, and molecular therapy depending on factors such as tumor location, size, and the patient's age and health status.
3. The main treatment goals are maximal tumor resection while preserving brain function, relieving symptoms like seizures, obtaining a diagnosis, and improving outcomes by delaying malignant transformation or progression to a high grade glioma.
This document provides a detailed overview of MRI findings for various spinal pathologies. It discusses preferred imaging sequences and protocols for evaluating the spine, bone marrow, nerves, and cerebrospinal fluid flow. Key points include:
- MRI is the preferred modality for identifying soft tissue and bone marrow abnormalities in the spine. T2-weighted, STIR, and gadolinium-enhanced sequences are often used.
- Dynamic, diffusion, and spectroscopy imaging can provide functional and physiological spinal information. Positioning patients in flexion and extension can identify disc abnormalities.
- Degenerative changes, disc herniations, fractures, infections, and tumors are described. Characteristic MRI patterns help differentiate benign from malignant lesions
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
5. Calcification; 90 % on CT scan
T2 - weighted well circumscribed, homogeneously
hyper-intense
T1 weighted, contrast enhanced, heterogenously hypo-
intense with no significant enhancement
70 % calcified; hypo intense on T1 and T2, but micro
calcification can demonstrate hyperintense on T1
weighted
Radiological Presentation
6.
7. 73% micro-calcification; 16 % cystic; 33- 41 % have
component of ependymal or neoplastic astrocytoma
Penetrate intact parenchyma
Fried egg appearance
Chicken wire vascular pattern
Round monotonous nuclei surrounding eccentric rim
of eosinophilic cytoplasm with lacked cell process
GFAP staining; mostly for astrocyte component
Pathology
8.
9. WHO class II (low grade)
WHO class III (High Grade)
Smith grading System; compose of five variables
o N/c ratio
o Maximal cell density
o Pleomorphism; related to Survival
o Endothelial proliferation
o Necrosis
Grading System
10.
11. 1p or 19 q or both allelic loss responses on
chemotherapy
PVC; Procarbazine 60 mg/m2 IV, CCNU aka lomustine
110 mg/ m2 PO, Vincristine 1.4 mg/m2 all given on 29
days cycle repeated every 6 weeks.
Chemotherapy
12. Indication of surgery
Significant mass effect regardless of grade
Without mass effect;
low grade: gross total resection; improve survival
High grade: no improvement in survival, either with
gross total or partial de bulking or biopsy
Pink to red friable mass, can have false plane of
demarcation between tumor and normal brain
parenchyma
Surgery
13. Controversial
Survival is better with > 45 Gy
No improvement in 5 year survival with or with out
XRT
Post operative Radiation
14. Pure ODG have better outcome from astrocyte
component
Median survival; grade A; 94 months, grade B; 51
months, grade C; 45 months and grade D; 17 months
10 year survival; surgically treated mean 52 months
Calcified; 108 months vs Non- calcified 58 month
Frontal lobe; 37 months vs temporal lobe; 28 months
Chromosome 1 p loss have longer survival
Prognosis